GEVO INC (GEVO)

US3743964062 - Common Stock

2.85  +0.53 (+22.84%)

After market: 2.93 +0.08 (+2.81%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to GEVO. GEVO was compared to 205 industry peers in the Oil, Gas & Consumable Fuels industry. The financial health of GEVO is average, but there are quite some concerns on its profitability. While showing a medium growth rate, GEVO is valued expensive at the moment.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year GEVO has reported negative net income.
In the past year GEVO has reported a negative cash flow from operations.
In the past 5 years GEVO always reported negative net income.
In the past 5 years GEVO always reported negative operating cash flow.

1.2 Ratios

GEVO has a Return On Assets of -13.17%. This is amonst the worse of the industry: GEVO underperforms 90.05% of its industry peers.
Looking at the Return On Equity, with a value of -15.75%, GEVO is doing worse than 81.59% of the companies in the same industry.
Industry RankSector Rank
ROA -13.17%
ROE -15.75%
ROIC N/A
ROA(3y)-11.11%
ROA(5y)-18.09%
ROE(3y)-12.96%
ROE(5y)-21.17%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 2.81%, GEVO is doing worse than 82.09% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for GEVO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

5

2. Health

2.1 Basic Checks

GEVO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GEVO has more shares outstanding
GEVO has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, GEVO has a worse debt to assets ratio.

2.2 Solvency

GEVO has an Altman-Z score of 2.25. This is not the best score and indicates that GEVO is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.25, GEVO is in the better half of the industry, outperforming 65.67% of the companies in the same industry.
A Debt/Equity ratio of 0.13 indicates that GEVO is not too dependend on debt financing.
GEVO has a Debt to Equity ratio of 0.13. This is in the better half of the industry: GEVO outperforms 76.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 2.25
ROIC/WACCN/A
WACC8.48%

2.3 Liquidity

GEVO has a Current Ratio of 8.25. This indicates that GEVO is financially healthy and has no problem in meeting its short term obligations.
GEVO has a Current ratio of 8.25. This is amongst the best in the industry. GEVO outperforms 94.03% of its industry peers.
GEVO has a Quick Ratio of 8.05. This indicates that GEVO is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of GEVO (8.05) is better than 94.53% of its industry peers.
Industry RankSector Rank
Current Ratio 8.25
Quick Ratio 8.05

More info and screens

5

3. Growth

3.1 Past

The earnings per share for GEVO have decreased by -9.68% in the last year.
GEVO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.53%.
The Revenue for GEVO have been decreasing by -12.14% on average. This is quite bad
EPS 1Y (TTM)-9.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.57%
Revenue 1Y (TTM)16.53%
Revenue growth 3Y45.88%
Revenue growth 5Y-12.14%
Sales Q2Q%-56.6%

3.2 Future

GEVO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 45.65% yearly.
The Revenue is expected to grow by 66.00% on average over the next years. This is a very strong growth
EPS Next Y-16.57%
EPS Next 2Y-0.09%
EPS Next 3Y17.39%
EPS Next 5Y45.65%
Revenue Next Year-13.26%
Revenue Next 2Y23.78%
Revenue Next 3Y120%
Revenue Next 5Y66%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GEVO. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GEVO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

GEVO's earnings are expected to grow with 17.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.09%
EPS Next 3Y17.39%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GEVO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GEVO INC

NASDAQ:GEVO (1/3/2025, 9:44:04 PM)

After market: 2.93 +0.08 (+2.81%)

2.85

+0.53 (+22.84%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners23.92%
Inst Owner Change-21.94%
Ins Owners4.52%
Ins Owner Change-7.29%
Market Cap682.32M
Analysts77.78
Price Target6.07 (112.98%)
Short Float %12.13%
Short Ratio3.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-16.12%
Min EPS beat(2)-17.65%
Max EPS beat(2)-14.59%
EPS beat(4)0
Avg EPS beat(4)-23.22%
Min EPS beat(4)-49.39%
Max EPS beat(4)-11.25%
EPS beat(8)0
Avg EPS beat(8)-30.45%
EPS beat(12)1
Avg EPS beat(12)-32.72%
EPS beat(16)1
Avg EPS beat(16)-38.9%
Revenue beat(2)1
Avg Revenue beat(2)-23.42%
Min Revenue beat(2)-64.45%
Max Revenue beat(2)17.62%
Revenue beat(4)1
Avg Revenue beat(4)-15.26%
Min Revenue beat(4)-64.45%
Max Revenue beat(4)17.62%
Revenue beat(8)4
Avg Revenue beat(8)-9.89%
Revenue beat(12)5
Avg Revenue beat(12)-17.57%
Revenue beat(16)5
Avg Revenue beat(16)-27.33%
PT rev (1m)0%
PT rev (3m)15.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)34.78%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.89%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-24.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-20.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 43.77
P/FCF N/A
P/OCF N/A
P/B 1.35
P/tB 1.39
EV/EBITDA N/A
EPS(TTM)-0.34
EYN/A
EPS(NY)-0.28
Fwd EYN/A
FCF(TTM)-0.42
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS0.07
BVpS2.11
TBVpS2.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.17%
ROE -15.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 2.81%
FCFM N/A
ROA(3y)-11.11%
ROA(5y)-18.09%
ROE(3y)-12.96%
ROE(5y)-21.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 174.5%
Cap/Sales 189.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.25
Quick Ratio 8.05
Altman-Z 2.25
F-Score4
WACC8.48%
ROIC/WACCN/A
Cap/Depr(3y)784.57%
Cap/Depr(5y)508.73%
Cap/Sales(3y)5816.93%
Cap/Sales(5y)3516.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.57%
EPS Next Y-16.57%
EPS Next 2Y-0.09%
EPS Next 3Y17.39%
EPS Next 5Y45.65%
Revenue 1Y (TTM)16.53%
Revenue growth 3Y45.88%
Revenue growth 5Y-12.14%
Sales Q2Q%-56.6%
Revenue Next Year-13.26%
Revenue Next 2Y23.78%
Revenue Next 3Y120%
Revenue Next 5Y66%
EBIT growth 1Y-6.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year35.36%
EBIT Next 3Y31.95%
EBIT Next 5Y29.52%
FCF growth 1Y33.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-26.23%
OCF growth 3YN/A
OCF growth 5YN/A